“Central site monitoring: results from a test of accuracy in identifying trials and sites failing Food and Drug Administration inspection.”, Clin Trials, vol. 11, no. 2, pp. 205-17, 2014.
, “Incentives and barriers to neurological clinical research participation.”, Clin Investig (Lond), vol. 1, no. 12, pp. 1663-1668, 2011.
, “Bringing better treatments to patients faster by expanding access.”, Arch Ophthalmol, vol. 127, no. 12, pp. 1674-5, 2009.
, “Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14.”, Arch Ophthalmol, vol. 123, no. 9, pp. 1207-14, 2005.
, “Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26.”, Arch Ophthalmol, vol. 127, no. 9, pp. 1168-74, 2009.
,